Vertellus Specialties Reaches Equity Transfer Agreement

INDIANAPOLIS, Nov. 12, 2010 /PRNewswire/ — Vertellus Specialties Inc. (the

“Company”), a leading specialty chemicals company, announced that it will be the
acquirer pursuant to an Equity Transfer Agreement reached on November 5, 2010.
Further details are available on the Company’s Form 8-K posted on the Company’s
confidential investor website.

About Vertellus Specialties Inc.

Vertellus is a specialty chemicals company focused on the manufacture of
ingredients used in pharmaceuticals, personal care, nutrition, agriculture, and
a host of other market areas affected by trends favoring “green” technologies
and chemistries. Vertellus is the #1 global producer of pyridine and picolines,
specialty pyridine derivatives, DEET, castor oil derivatives and systems and the
world’s #2 producer of Vitamin B-3 and citrate polymer additives. Vertellus
benefits from a technically advanced global manufacturing base and has
approximately 700 employees. Vertellus is headquartered in Indianapolis,
Indiana. Vertellus is owned by Wind Point Partners, a private equity firm based
in Chicago. Wind Point acquired Vertellus in 2007 through Wind Point VI, a $715
million fund. Further information is available at www.vertellus.com.

Contact: David Schwind
Vertellus Specialties
317-248-6478

Roland Tomforde
Broadgate Consultants
212-232-2222

SOURCE Vertellus Specialties Inc.